Caxton Associates (UK)’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,500
Closed -$704K 784
2026
Q1
$704K Sell
2,500
-5,200
-68% -$1.51M 0.02% 449
2025
Q4
$2.28M Sell
7,700
-4,491
-37% -$1.35M 0.04% 166
2025
Q3
$3M Buy
+12,191
New +$2.46M 0.07% 129
2025
Q2
Sell
-36,000
Closed -$2.84M 713
2025
Q1
$2.84M Buy
+36,000
New +$3.82M 0.1% 99

Other funds holding CLS

Caxton Associates (UK)'s CLS Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Celestica (CLS) in Q2 2026, closing a stake of 2,500 shares — an estimated $704K sold.

Caxton Associates (UK) first reported a position in CLS in Q1 2025 and held it in 4 quarters. The position peaked at $3M in Q3 2025. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Celestica position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 2,500 Celestica shares in Q2 2026, an estimated $704K.
  • Caxton Associates (UK) first reported a position in Celestica in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Celestica position peaked at $3M in Q3 2025.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.